Direct oral anticoagulants versus warfarin in patients with single antibody-positive anti-phospholipid syndrome.
Angela LiuKarishma Vijay RupaniLeonard NaymagonPublished in: European journal of haematology (2022)
These findings suggest that DOACs may be a safe and effective option for patients with single-positive APLS. Prospective studies are needed to confirm these findings.